Right Bundle Branch Block of Unknown Age in the Setting of Acute Anterior Myocardial Infarction: An Attempt to Define Who Should Be Paced Prophylactically-Reference-Cited by-同舟云学术

Right Bundle Branch Block of Unknown Age in the Setting of Acute Anterior Myocardial Infarction: An Attempt to Define Who Should Be Paced Prophylactically

Published:1995-08 Issue:8 Volume:18 Page:1496-1508
ISSN:0147-8389
Container-title:Pacing and Clinical Electrophysiology
language:en
Short-container-title:Pacing Clin Electro

Author:

ROTH ARIE,BORSUK YOAV,KEREN GAD,SHEPS DAVID,CLICK AHRON,REICHER MEIR,LANIADO SHLOMO

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1540-8159.1995.tb06736.x/fullpdf

Reference41 articles.

1. The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion.

2. The significance of bundle branch block during acute myocardial infarction

3. Ventricular Conduction Blocks and Sudden Death in Acute Myocardial Infarction

4. Complete Bundle-Branch Block Complicating Acute Myocardial Infarction

5. Factors Influencing Prognosis of Bundle Branch Block Complicating Acute Antero-Septal Infarction

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart block and conduction disturbances;Current Treatment Options in Cardiovascular Medicine;1999-08

2. Atrioventricular and Intraventricular Conduction Disorders in Acute Myocardial Infarction: A Reappraisal in the Thrombolytic Era;Pacing and Clinical Electrophysiology;1998-12

3. Predictors of in-hospital bundle branch block reversion after presenting with acute myocardial infarction and bundle branch block;The American Journal of Cardiology;1998-08

4. Acute Myocardial Infarction and Complete Bundle Branch Block at Hospital Admission: Clinical Characteristics and Outcome in the Thrombolytic Era fn1fn1This study was supported by grants from Bayer Corporation, New York, New York; Genentech, Inc., South San Francisco, California; CIBA-Corning, Medford, Massachusetts; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.;Journal of the American College of Cardiology;1998-01